Since licensing the CrossFire databases in 2004, WuXi PharmaTech (NYSE: WX), the leading Chinese pharmaceutical and biotechnology R&D outsourcing company, has become the largest user of CrossFire Beilstein on CrossFire Direct.
"WuXi PharmaTech (NYSE: WX) relies on the high quality and relevance of the experimental data in CrossFire Beilstein," says Dr. Ge Li, CEO of WuXi PharmaTech. "The factual Beilstein database is an indispensable resource supporting WuXi PharmaTech's global pharmaceutical and biotechnology R&D outsourcing solutions."
CrossFire Beilstein is available online through CrossFire Commander, where the database is hosted on CrossFire Direct, or it is accessible via in-house hosting. Researchers can also access CrossFire Beilstein via DiscoveryGate(R), a comprehensive online cheminformatics content platform offered by MDL Information Systems Inc.
For information on searching reactions, substances and publications using CrossFire Beilstein, visit http://www.crossfirebeilstein.com.
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with
|SOURCE Elsevier B V|
Copyright©2007 PR Newswire.